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Abstract
Aims/hypothesis The aim of this work was to investigate
hepatic lipid metabolic processes possibly involved in the
reduction of liver fat content (LF) observed in patients with
type 2 diabetes after an isoenergetic diet enriched in
monounsaturated fatty acids (MUFAs).
Methods This is an ancillary analysis of a published study. In a
parallel-group design, 30 men and eight women, aged
35–70 years, with type 2 diabetes and whose blood glucose was
controlled satisfactorily (HbA1c<7.5% [58mmol/mol]) by diet or
diet plus metformin, were randomised by MINIM software to
follow either a high-carbohydrate/high-fibre/low-glycaemic index
diet (CHO/fibre diet, n=20) or a high-MUFA diet (MUFA diet,
n=18) for 8 weeks. The assigned diets were known for the par-
ticipants and blinded for people doing measurements. Before and
after intervention, LF was measured by 1H-MRS (primary
outcome) and indirect indices of de novo lipogenesis (DNL)
(serum triacylglycerol palmitic:linoleic acid ratio), stearoyl-CoA
desaturase activity (SCD-1) (serum triacylglycerol
palmitoleic:palmitic acid ratio) and hepatic β-oxidation of fatty
acids (β-hydroxybutyrate plasma concentrations) were measured.
Results LF was reduced by 30% after the MUFA diet, as
already reported. Postprandialβ-hydroxybutyrate incremental
AUC (iAUC) was significantly less suppressed after the
MUFA diet (n = 16) (−2504 ± 4488 μmol/l × 360 min vs
baseline −9021 ± 6489 μmol/l × 360 min) while it was
unchanged after the CHO/fibre diet (n = 17) (−8168
±9827 μmol/l × 360 min vs baseline −7206±10,005 μmol/
l × 360 min, p = 0.962) (mean ± SD, p = 0.043). In the
participants assigned to the MUFA diet, the change in
postprandial β-hydroxybutyrate iAUC was inversely
associated with the change in LF (r=−0.642, p= 0.010).
DNL and SCD-1 indirect indices did not change significantly
after either of the dietary interventions.
Conclusions/interpretation Postprandial hepatic oxidation of
fatty acids is a metabolic process possibly involved in the
reduction of LF by a MUFA-rich diet in patients with type 2
diabetes.
Trial registration ClinicalTrials.gov NCT01025856
Funding The study was funded by Ministero Istruzione
Università e Ricerca and Italian Minister of Health.
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Introduction
Fatty liver is associated with type 2 diabetes [1] and dietary
approaches useful for type 2 diabetes treatment also improve
fatty liver [2]. We previously reported that an isoenergetic diet
rich in monounsaturated fatty acids (MUFAs) induced a
clinically relevant reduction (−30%) in liver fat content (LF)
in patients with type 2 diabetes [3]. The mechanisms behind
this effect are unknown and may relate to the complex
interactions between anabolic and catabolic hepatic pathways,
including the following: (1) the uptake of NEFA derived
from adipose tissue lipolysis, chylomicron remnants and
intravascular hydrolysis of triacylglycerol-rich lipoproteins;
(2) post-absorptive de novo lipogenesis (DNL), which is
15–25% higher in people with fatty liver and stimulated under
conditions of excess carbohydrate intake [4]; (3) desaturation
of saturated fatty acids (SFAs) to MUFAs by stearoyl-CoA
desaturase (SCD-1), a process that is linked to DNL and
occurs to a greater extent in individuals with fatty liver, likely
being an adaptation to the excessive availability of SFAs [5];
(4) β-oxidation of fatty acids and ketogenesis, which are
increased in people with obesity and hypertriglyceridaemia
and likely prevent excess fat deposition in the liver [5] and
(5) fatty acid secretion as circulating VLDL-triacylglycerols.
In this ancillary analysis of a published randomised
controlled trial [3], we evaluated hepatic DNL, SCD1 activity
and β-oxidation in a cohort with type 2 diabetes in whom
a MUFA-rich diet resulted in a significant reduction of
LF.
Methods
Participants Individuals with type 2 diabetes of both sexes
were recruited at Federico II University Medical School
Hospital and enrolled after giving their written informed
consent. Participants were overweight or obese, without body
weight changes over the previous 6 months, had satisfactory
blood glucose control (HbA1c < 7.5% [58 mmol/mol]) by
means of diet or metformin plus diet, were not on
lipid-lowering drugs and had no evidence of liver disease
apart from non-alcoholic steatosis. The main characteristics
of the participants in this study (n=33) are reported in ESM
Table 1.
The trial design was approved by the Federico II University
Ethics Committee and registered at ClinicalTrials.gov
(registration no. NCT01025856).
Study design In a 2×2 parallel-group factorial design, after
a 3 week run-in on a diet similar to their habitual diet
(carbohydrate 48%, total fat 33%, saturated fat 13% and
protein 18% of total energy intake), participants were randomly
assigned to one of the following 8 week interventions: (1)
high-carbohydrate/high-fibre/low-glycaemic index diet (CHO/
fibre diet); (2) high-MUFA diet (MUFA diet); (3) CHO/fibre
diet plus physical training; (4) MUFA diet plus physical
training [3]. The assigned experimental diets were isoenergetic
in order to keep body weight constant and differed in
macronutrient composition for CHO/fibre diet vs MUFA diet,
respectively: carbohydrate 52% vs 40%, fibre 28 vs 10 g/
4184 kJ, glycaemic index (bread reference) 60% vs 95%, fat
30% vs 42% and MUFA 16% vs 28%. The diets followed are
reported in ESM Table 2. Since in the original trial, light
physical training was found to have no significant effect on
LF, in the present study data were pooled according to diet only
(i.e. CHO/fibre diet or MUFA diet), independently of the
physical training, which was performed by ten participants in
the CHO/fibre-diet group and eight participants in the MUFA
diet group [3]. Before and after intervention, anthropometrics,
LF measurement (proton magnetic resonance spectroscopy,
1H-MRS) and blood sampling before and after a test meal were
performed. Test meals had a similar composition to the habitual
diet of the study population at baseline, but were high in CHO/
fibre or MUFA, according to the assigned experimental diet,
after the intervention [3].
β-oxidation of fatty acids was assessed by measuring
plasma β-hydroxybutyrate concentrations before and 180
and 360 min after the test meals [6]. DNL was assessed by
calculating the ratio of palmitoleic to palmitic acid (C16:1/
C16:0) in fasting serum triacylglycerols [4]. SCD-1 activity
was assessed by calculating the ratio of palmitic to linoleic
acid (C16:0/C18:2n6) in fasting serum triacylglycerols [7].
Laboratorymethods Plasmaβ-hydroxybutyrate concentrations
were evaluated by an enzymatic endpoint method (DiaSys
Diagnostic Systems, Holzheim, Germany) on an automated
photometric analyser (ABX-Pentra 400; Horiba Medical, Kyoto,
Japan). Samples were analysed in triplicate; normal and
pathological reference samples were assayed in each batch for
internal quality control. Palmitic, linoleic and palmitoleic acid
levels in serum triacylglycerol fraction were analysed by gas
chromatography. Briefly, serum lipids were extracted and
triacylglycerols isolated by solid-phase extraction by standard
procedures [8].Methyl esters of fatty acids of triacylglycerolswere
prepared and analysed by gas chromatography with flame
ionisation (DANI Instruments GC 1000, Cologno Monzese,
Italy).
Statistical analysis Data are expressed as means±SD unless
otherwise stated. Postprandial β-hydroxybutyrate incremental
area under the curve (iAUC) was calculated by the trapezoidal
rule as the 0–6 h AUC minus the area below the fasting value
[9].
Between-treatments differences were evaluated by
ANCOVA general linear model taking the 8 week values as
dependent variables, the diet treatments as fixed factor and
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baseline values as covariates. Within groups, before–after
intervention differences were evaluated by paired t test.
Bivariate associations were assessed by Pearson correlation.
A p value < 0.05 was considered significant. Statistical
analysis was performed according to standard methods using
the SPSS software 20.0 (SPSS/PC; IBM, Armonk, NY, USA).
Results
At baseline, the MUFA or CHO/fibre groups did not differ
significantly for age, BMI, fasting plasma glucose and lipids
concentrations or HbA1c (ESM Table 1). As previously
reported [3], LF was decreased by a significantly greater
extent after the MUFA diet than after the CHO/fibre diet
(−27±30% vs −6±25%, respectively, p=0.034). Moreover,
HbA1c and fasting plasma triacylglycerol concentrations
improved after the MUFA diet [3].
DNL The DNL index, measured as the ratio of palmitic to
linoleic acid concentration, did not change after either the
MUFA diet (4.18±2.20 vs baseline 4.39±2.59, p=0.799) or
the CHO/fibre diet (3.35 ± 1.78 vs baseline 4.23 ± 2.69,
p=0.176).
Desaturase activity SCD-1 activity, measured as the ratio of
palmitoleic to palmitic acid concentration, did not change after
either the MUFA diet (0.17 ± 0.16 vs baseline 0.19 ± 0.20,
p= 0.978) or the CHO/fibre diet (0.17 ± 0.13 vs baseline
0.23±0.29, p=0.424).
Fatty acid β-oxidation Figure 1 presents the fatty acid
β-oxidation outcomes. Fasting plasma concentrations of
β-hydroxybutyrate decreased significantly after the MUFA
diet (65±16 vs baseline 84±24 μmol/l, p=0.015) but did
not change after the CHO/fibre diet (80±45 vs baseline 78
± 32 μmol/l, p= 0.860), with a non-significant difference
between the two diets (p=0.083).β-oxidation was suppressed
during the postprandial period both at baseline and after
dietary treatments, as shown by the lower concentrations of
β-hydroxybutyrate after meals. Postprandial β-hydroxybutyrate
iAUC was significantly less suppressed after the MUFA diet
(−2504±4488 vs baseline −9021±6489 μmol/l × 360 min,
p=0.003), while it remained unchanged after the CHO/fibre diet
(−8168±9827 vs baseline −7206±10,005 μmol/l×360 min,
p=0.962), with a significant difference between the two diets
(p=0.043).
In the MUFA diet group, the change in postprandial
β-hydroxybutyrate iAUC induced by the intervention was
inversely associated with the change in LF (r = −0.642,
p=0.010) as shown in Fig. 2.
Discussion
In this study, postprandial hepatic fat oxidation was enhanced
by an 8 week MUFA-rich diet resulting in significantly
reduced LF, compared with a CHO/fibre diet. The
postprandial suppression of β-oxidation was associated with
a greater reduction in LF induced by the MUFA diet.
As a marker of hepatic β-oxidation we used plasma
β-hydroxybutyrate concentration. NEFA oxidation generates
intramitochondrial acetyl-CoA, which may either enter the
Krebs cycle for oxidation to CO2 or produceβ-hydroxybutyrate.
The proportional contribution of ketogenesis to the overall
NEFA oxidation is still unclear, with a higher partitioning to
ketogenic pathways in obese individuals than in lean ones [10].
Kinetic studies indicate that a postprandial increase in
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Fig. 1 (a, b) β-hydroxybutyrate
(β-OHB) plasma concentrations
before and after the test meal at
baseline (dashed line) and end of
intervention (solid line) in the
CHO/fibre group (a) and MUFA
group (b). (c, d) Postprandial
β-OHB iAUC at baseline and end
of intervention in the CHO/fibre
group (c) and MUFA group (d).
Data are shown as means ± SE.
*p< 0.05 vs baseline (paired
sample t test). §p= 0.043 for
differences between changes in
the two groups by ANCOVA
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β-hydroxybutyrate production may be an adaptive mechanism
to prevent LF accumulation in individuals needing to handle an
energy oversupply. In line with this, in our study the increase in
β-oxidation during the postprandial phase directly correlated
with LF reduction in the MUFA diet group, corroborating the
hypothesis that increasing fat oxidation is a main pathway to
avoidance or reduction of liver fat deposition.
The increase in postprandial β-oxidation well integrates
with the pleiotropic metabolic effects already shown for
dietary MUFA. In the intestine, MUFAs are preferentially
incorporated into a greater number of larger chylomicrons,
which are hydrolysed faster than the smaller ones. This
produces a higher proportion of MUFA in the postprandial
NEFA pool more prone to oxidation, and therefore less prone
to deposition, with respect to other types of fat [11]. Another
likely mechanism underlying the effects of MUFAs on LF is
that dietary MUFAs reaching the liver may be preferentially
incorporated in VLDL and exported to adipose tissue [11].
Consistent with these observations, in our study the MUFA
diet increased postprandial triacylglycerol concentrations in
the chylomicron plus VLDL fraction, as previously reported
[12].
No significant effects of the dietary intervention were
observed on the indices of DNL and SCD-1 activity,
indicating that these processes may not be directly involved
in the reduction of LF by dietary MUFA. The lack of effect on
the DNL and desaturase pathways, which are related to
increased LF after very-high-carbohydrate intake [4], suggests
that the reduction in LF observed in our study was unlikely to
be related to the slightly lower carbohydrate content of the
MUFA diet than the CHO/fibre diet [2].
A limitation of this study is the use of indirect markers of
DNL and SCD-1 activity. Moreover, althoughβ-hydroxybutyrate
is widely accepted as a reliable marker ofβ-oxidation, its unstable
chemical nature and the fact that its plasma concentrations result
from the net balance between hepatic production and peripheral
utilisation may represent some limitations for the interpretation of
our results.
In conclusion, the reduction in LF obtained in individuals
with type 2 diabetes receiving a MUFA-rich diet is associated
with the modulation of the postprandial metabolic
environment towards usage, rather than storage, of energy
oversupply through the stimulation of postprandial hepatic
oxidation of fatty acids.
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